Home2019CSI Singapore Welcomes New Director, Professor Ashok Venkitaraman
CSI Singapore Welcomes New Director, Professor Ashok Venkitaraman
The Cancer Science Institute of Singapore (CSI Singapore) is pleased to announce the appointment of Professor Ashok Venkitaraman as the new Director of CSI Singapore. Prof Venkitaraman will take over the reins from CSI Singapore’s Founding Director, Professor Daniel G Tenen after a period of transition from his current appointments at the University of Cambridge, where he served as the Ursula Zoellner Professor of Cancer Research and Director of the Medical Research Council Cancer Unit.
Prof Venkitaraman will become a Distinguished Professor in the Department of Medicine at the NUS Yong Loo Lin School of Medicine, a member of the National University Health System (NUHS). He will also take up appointments as Senior Principal Investigator and Senior Adviser at the Agency for Science, Technology and Research (A*STAR).
Widely recognized for his meritorious contributions in the field of cancer research, Prof Venkitaraman’s work has laid the foundation for our understanding of how cancer is suppressed by genes that maintain the integrity of DNA in the human genome. His scientific pursuits have also made inroads into the field of cancer genetics and biology, including a pivotal discovery that elucidates the impact of genome instability on carcinogenesis and cancer therapy. Moving forward, Prof Venkitaraman aims to achieve a deeper understanding of the steps that underlie carcinogenesis, in order to accelerate advances that will lead to better cancer treatment outcomes.
“I look forward with great enthusiasm to leading the Cancer Science Institute of Singapore at NUS, and to working with colleagues at NUS, NUHS, A*STAR and across Singapore. Cancer remains a major cause of illness and death across Asia and worldwide. But the tide is turning, and rapid advances in scientific understanding driven by fundamental research promise to fuel the innovation that will reduce the burden of illness and death from this dreaded disease. CSI Singapore aspires to remain at the forefront of this vital research.” said Prof Venkitaraman.
Since its inception in 2008, CSI Singapore has established itself as a dynamic research institute encompassing basic and translational studies devoted to understanding the pathogenesis and treatment of cancer. Helmed by Prof Tenen over the past decade, CSI Singapore has achieved recognition through numerous awards and honours conferred on its outstanding scientists and students. Under Prof Venkitaraman’s leadership, CSI Singapore will continue to explore better ways to prevent, diagnose and revolutionize cancer treatment in Singapore and the world.
Please join us in welcoming Professor Ashok Venkitaraman to CSI Singapore!
Find out more about the appointment of Prof Venkitaraman here.